ID: ALA2235250

Max Phase: Preclinical

Molecular Formula: C16H12O6

Molecular Weight: 300.27

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COc1c(O)cc(O)c2c(=O)cc(-c3ccccc3O)oc12

Standard InChI:  InChI=1S/C16H12O6/c1-21-15-12(20)6-10(18)14-11(19)7-13(22-16(14)15)8-4-2-3-5-9(8)17/h2-7,17-18,20H,1H3

Standard InChI Key:  XCBMYKIKEHGYAR-UHFFFAOYSA-N

Associated Targets(non-human)

Avian myoblastosis virus polyprotein II 68 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 300.27Molecular Weight (Monoisotopic): 300.0634AlogP: 2.59#Rotatable Bonds: 2
Polar Surface Area: 100.13Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 6HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.07CX Basic pKa: CX LogP: 2.55CX LogD: 2.01
Aromatic Rings: 3Heavy Atoms: 22QED Weighted: 0.67Np Likeness Score: 1.48

References

1. Phosrithong N, Samee W, Ungwitayatorn J.  (2012)  3D-QSAR studies of natural flavonoid compounds as reverse transcriptase inhibitors,  21  (5): [10.1007/s00044-011-9570-z]

Source